Skip to main content

Tokyo Office Presents ‘Insiders’ Views of Deal Making in the Life Sciences Sector’

BOSTON – Oct. 22, 2019 Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group is co-hosting the seminar, “Insiders’ Views of Deal Making in the Life Sciences Sector,” with German biotech strategy consulting firm, Catenion. The seminar will take place from 16:00 – 18:00 p.m. on Oct. 25, 2019, at Greenberg Traurig’s Tokyo office.

Speakers from Greenberg Traurig and Catenion will discuss best practices and practical tips in deal making, as well as pitfalls in M&A, licensing, joint ventures, and strategic collaborations. Presentations will be followed by a panel discussion about recent trends and challenges involving international deal-making in the life sciences sector.

Co-chair of Greenberg Traurig’s Japan Practice Koichiro Ohashi will deliver the program's opening remarks. Other speakers include:

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig’s Tokyo Office: Greenberg Traurig’s Tokyo office comprises an award-winning team of attorneys and professionals, who provide multinational and Japanese clients with innovative, strategic advice and legal services in a market known as a gateway to international business opportunities. Utilizing an understanding of the local culture and practical aspects of Japanese business, the firm’s multidimensional team offers custom strategies to fulfill client needs.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: Twitter: @GT_Law.